As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery ...

On the profitability front, we expect the EBIT margin to expand to 4.0% by fiscal 2029 from 3.8% in fiscal 2024. This is based on volume-driven operational efficiencies, increasing capacity ...

I believe it's time healthcare delivery leverages the technological innovations that have rapidly redefined how the retail ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

CFIUS approved a 2018 purchase of GNC shares by China-based Harbin Pharmaceutical based on no "unresolved national security ...

The debate in Illinois is part of a larger battle over the discounts drugmakers give health care providers for drugs that go ...

At the Bangladesh Investment Summit 2025, Chief Adviser Muhammad Yunus handed over the award to bKash founder and CEO Kamal Quadir on Wednesday ...

Following a second measles-related death in Texas, Robert F. | The HHS secretary called out the measles vaccines as "the most ...

Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.